Anthony Mack
Fondateur chez IACTA Pharmaceuticals, Inc.
Fortune : 208 809 $ au 31/05/2024
Profil
Anthony P.
Mack was the founder of Scilex Pharmaceuticals, Inc. (founded in 2011) where he served as the Chief Executive Officer & Director from 2011 to 2018.
He was also the founder of ProSolus Pharmaceuticals LP (founded in 2009) where he held the position of President & Director from 2009 to 2015.
Additionally, Mr. Mack was the founder of Virpax Pharmaceuticals, Inc. (founded in 2016) and served as the Chairman & Chief Executive Officer.
Mr. Mack is also the founder of IACTA Pharmaceuticals, Inc...- Mr. Mack's education history includes an MBA from St. Joseph's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VIRPAX PHARMACEUTICALS, INC.
10,88% | 03/06/2024 | 298 298 ( 10,88% ) | 208 809 $ | 31/05/2024 |
Postes actifs de Anthony Mack
| Sociétés | Poste | Début |
|---|---|---|
IACTA Pharmaceuticals, Inc.
 IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Fondateur | - |
Anciens postes connus de Anthony Mack
| Sociétés | Poste | Fin |
|---|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Directeur Général | 17/11/2023 |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Fondateur | 01/02/2018 |
ProSolus Pharmaceuticals LP
 ProSolus Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Mission Pharmacal Co., ProSolus Pharmaceuticals LP is a company that manufactures and supplies pharmaceutical products. The company is based in Miami, FL. The company was founded by Anthony P. Mack. ProSolus Pharmaceuticals was acquired by Mission Pharmacal Co. on June 09, 2015. | Fondateur | 01/06/2015 |
Formation de Anthony Mack
| St. Joseph's University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
ProSolus Pharmaceuticals LP
ProSolus Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Part of Mission Pharmacal Co., ProSolus Pharmaceuticals LP is a company that manufactures and supplies pharmaceutical products. The company is based in Miami, FL. The company was founded by Anthony P. Mack. ProSolus Pharmaceuticals was acquired by Mission Pharmacal Co. on June 09, 2015. | Health Technology |
IACTA Pharmaceuticals, Inc.
IACTA Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology IACTA Pharmaceuticals, Inc. develops and commercializes eyecare products. Its products include IC 265, for dry eye, and IC 270, for allergic conjunctivitis. The company was founded by Damon Burrows, William Pedranti, and George K. Ng in 2016 and is headquartered in Irvine, CA. | Health Technology |
